High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis von Jindani, Amina, Harrison, Thomas S, Nunn, Andrew J, Phillips, Patrick P.J, Churchyard, Gavin J, Charalambous, Salome, Hatherill, Mark, Geldenhuys, Hennie, McIlleron, Helen M, Zvada, Simbarashe P, Mungofa, Stanley, Shah, Nasir A, Zizhou, Simukai, Magweta, Lloyd, Shepherd, James, Nyirenda, Sambayawo, van Dijk, Janneke H, Clouting, Heather E, Coleman, David, Bateson, Anna L.E, McHugh, Timothy D, Butcher, Philip D, Mitchison, Denny A

Volltext

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial von Witney, Adam A, Bateson, Anna L E, Jindani, Amina, Phillips, Patrick P J, Coleman, David, Stoker, Neil G, Butcher, Philip D, McHugh, Timothy D

Volltext

Rifaquin Trial. High-Dose Rifapentine with Moxifoxacin for Pulmonary Tuberculosis (Rifaquin) von Jindani, Amina, S. Harrison, Thomas, Nunn, Andrew J., Phillips, Patrick P.J., Churchyard, Gavin J., Charalambous, Salome, Hatherill, Mark, Geldenhuys, Hennie, McIlleron, Helen M., Zvada, Simbarashe P., Mungofa, Stanley, Shah, Nasir A., Zizhou, Simukai, Magweta, Lloyd, Shepherd, James, Nyirenda, Sambayawo, van Dijk, Janneke H., Clouting, Heather E., Coleman, David, Bateson, Anna L.E., McHugh, Timothy D, Butcher, Philip D, Mitchison, Denny A.

Volltext bestellen